These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 30544204)
1. Advanced glycation end products of bovine serum albumin affect the cell growth of human umbilical vein endothelial cells via modulation of MEG3/miR-93/p21 pathway. Ju C; Sheng Z; Wang Q; Li Y; Wang X; Li S; Qi Q; Yuan Z Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):41-50. PubMed ID: 30544204 [TBL] [Abstract][Full Text] [Related]
2. The TGF-β1 Induces the Endothelial-to-Mesenchymal Transition via the UCA1/miR-455/ZEB1 Regulatory Axis in Human Umbilical Vein Endothelial Cells. Zhang Y; Fan K; Xu X; Wang A DNA Cell Biol; 2020 Jul; 39(7):1264-1273. PubMed ID: 32584608 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-210 Plays a Critical Role in the Angiogenic Effect of Isoprenaline on Human Umbilical Vein Endothelial Cells via Regulation of Noncoding RNAs. Yan YY; Wang ZH; Zhao L; Song DD; Qi C; Liu LL; Wang JN Chin Med J (Engl); 2016 Nov; 129(22):2676-2682. PubMed ID: 27823999 [TBL] [Abstract][Full Text] [Related]
4. Paeoniflorin protects HUVECs from AGE-BSA-induced injury via an autophagic pathway by acting on the RAGE. Chen Y; Du X; Zhou Y; Zhang Y; Yang Y; Liu Z; Liu C; Xie Y Int J Clin Exp Pathol; 2015; 8(1):53-62. PubMed ID: 25755692 [TBL] [Abstract][Full Text] [Related]
5. Atorvastatin protects cardiac progenitor cells from hypoxia-induced cell growth inhibition via MEG3/miR-22/HMGB1 pathway. Su J; Fang M; Tian B; Luo J; Jin C; Wang X; Ning Z; Li X Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1257-1265. PubMed ID: 30481260 [TBL] [Abstract][Full Text] [Related]
6. LncRNA-H19 acts as a ceRNA to regulate HE4 expression by sponging miR-140 in human umbilical vein endothelial cells under hyperglycemia with or without α-Mangostin. Luo Y; Fang Z; Ling Y; Luo W Biomed Pharmacother; 2019 Oct; 118():109256. PubMed ID: 31362245 [TBL] [Abstract][Full Text] [Related]
7. Silencing of MEG3 inhibited ox-LDL-induced inflammation and apoptosis in macrophages via modulation of the MEG3/miR-204/CDKN2A regulatory axis. Yan L; Liu Z; Yin H; Guo Z; Luo Q Cell Biol Int; 2019 Apr; 43(4):409-420. PubMed ID: 30672051 [TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells. He C; Yang W; Yang J; Ding J; Li S; Wu H; Zhou F; Jiang Y; Teng L; Yang J DNA Cell Biol; 2017 Jun; 36(6):475-481. PubMed ID: 28418724 [TBL] [Abstract][Full Text] [Related]
9. Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells. Lei H; Li H; Tian L; Li M; Xin Z; Zhang X; Guan R Drug Des Devel Ther; 2018; 12():1743-1751. PubMed ID: 29942117 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NEAT1 inhibits oxidative stress-induced vascular endothelial cell injury by activating the miR-181d-5p/CDKN3 axis. Zhang M; Wang X; Yao J; Qiu Z Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3129-3137. PubMed ID: 31352814 [TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products of bovine serum albumin-induced endothelial-to-mesenchymal transition in cultured human and monkey endothelial cells via protein kinase B signaling cascades. Ma J; Liu T; Dong X Mol Vis; 2010 Dec; 16():2669-79. PubMed ID: 21179235 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products inhibit glucose-6-phosphate dehydrogenase activity and expression in human umbilical vein endothelial cells. He MH; Zhang Y Sheng Li Xue Bao; 2012 Dec; 64(6):646-50. PubMed ID: 23258327 [TBL] [Abstract][Full Text] [Related]
13. MEG3 damages fetal endothelial function induced by gestational diabetes mellitus via AKT pathway. Ye HH; Yang SH; Zhang Y Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8553-8560. PubMed ID: 30575893 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MEG3 prevents vascular endothelial cell senescence by impairing miR-128-dependent Girdin downregulation. Lan Y; Li YJ; Li DJ; Li P; Wang JY; Diao YP; Ye GD; Li YF Am J Physiol Cell Physiol; 2019 Jun; 316(6):C830-C843. PubMed ID: 30576236 [TBL] [Abstract][Full Text] [Related]
15. Long intergenic noncoding RNA 00305 sponges miR-136 to regulate the hypoxia induced apoptosis of vascular endothelial cells. Zhang BY; Jin Z; Zhao Z Biomed Pharmacother; 2017 Oct; 94():238-243. PubMed ID: 28763747 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040 [TBL] [Abstract][Full Text] [Related]
17. Glucose-dependent insulinotropic polypeptide (GIP) inhibits signaling pathways of advanced glycation end products (AGEs) in endothelial cells via its antioxidative properties. Ojima A; Matsui T; Maeda S; Takeuchi M; Yamagishi S Horm Metab Res; 2012 Jun; 44(7):501-5. PubMed ID: 22581648 [TBL] [Abstract][Full Text] [Related]
18. LncRNA NEAT1 promotes colorectal cancer cell proliferation and migration via regulating glial cell-derived neurotrophic factor by sponging miR-196a-5p. Zhong F; Zhang W; Cao Y; Wen Q; Cao Y; Lou B; Li J; Shi W; Liu Y; Luo R; Chen C Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1190-1199. PubMed ID: 30383193 [TBL] [Abstract][Full Text] [Related]
19. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Pugliese G; Pricci F; Leto G; Amadio L; Iacobini C; Romeo G; Lenti L; Sale P; Gradini R; Liu FT; Di Mario U Diabetes; 2000 Jul; 49(7):1249-57. PubMed ID: 10909985 [TBL] [Abstract][Full Text] [Related]
20. miR-185 affected the EMT, cell viability, and proliferation via DNMT1/MEG3 pathway in TGF-β1-induced renal fibrosis. Xue R; Li Y; Li X; Ma J; An C; Ma Z Cell Biol Int; 2019 Oct; 43(10):1152-1162. PubMed ID: 30095214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]